XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Condensed Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock Outstanding [Member]
Common Stock Including Additional Paid in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Common [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2023 13,173,569          
Balance at Dec. 31, 2023   $ 173,637 $ 140,017 $ (56,015) $ (22,336) $ 235,303
Net income     1,915     1,915
Other comprehensive income (loss), net of taxes         (1,118) (1,118)
Dividend Reinvestment and Stock Purchase Plan (in shares) 9,004          
Dividend Reinvestment and Stock Purchase Plan   130       130
Shares issued for restricted stock awards (in shares) 41,703          
Shares issued for restricted stock awards           0
Compensation expense relating to restricted stock   315       315
Common stock dividends     (2,882)     (2,882)
Balance (in shares) at Mar. 31, 2024 13,224,276          
Balance at Mar. 31, 2024   174,082 139,050 (56,015) (23,454) 233,663
Balance (in shares) at Dec. 31, 2024 14,118,040          
Balance at Dec. 31, 2024   186,937 141,290 (56,002) (19,189) 253,036
Net income     4,609     4,609
Other comprehensive income (loss), net of taxes         3,662 3,662
Dividend Reinvestment and Stock Purchase Plan (in shares) 9,925          
Dividend Reinvestment and Stock Purchase Plan   148       148
Shares issued for restricted stock awards (in shares) 38,950          
Shares issued for restricted stock awards           0
Compensation expense relating to restricted stock   284       284
Common stock dividends     (3,088)     (3,088)
Balance (in shares) at Mar. 31, 2025 14,166,915          
Balance at Mar. 31, 2025   $ 187,369 $ 142,811 $ (56,002) $ (15,527) $ 258,651